enGenes Biotech Brings Its E. coli Toolbox to BIO-Europe 2026

Vienna, Austria: – enGenes Biotech to meet partners on the NorthX Biologics booth in Cologne, 9–11 November.

Got a protein that won’t express? enGenes Biotech wants to hear about it at BIO-Europe 2026.

The recombinant proteins and plasmid DNA specialist CDMO will join the booth of its partner NorthX Biologics, the Swedish GMP CDMO, at Koelnmesse, Cologne, from 9 to 11 November. Business Development Manager Ophelia Gevaert will be on hand to meet companies looking for a partner in recombinant protein, peptide and plasmid DNA production.

“BIO-Europe is where developers bring their toughest production problems, and that’s exactly where our E. coli platform shines,” said Ophelia Gevaert, Business Development Manager at enGenes Biotech. “Whether it’s a hard-to-express protein, a cell-toxic molecule or plasmid DNA at scale, we want to hear about it in Cologne.”

Five Technologies, One Workhorse Host

At the core of enGenes’ offer is a family of E. coli expression technologies, each built to solve a specific production headache:

-e^Xpress™ decouples cell growth from recombinant expression, delivering higher yields, tighter process control and access to hard-to-express proteins.

To read more, visit: https://www.pharmaceutical-networking.com/engenes-biotech-brings-its-e-coli-toolbox-to-bio-europe-2026/